Breath Analysis News and Research

RSS
Keensight Capital acquires majority stake in Bedfont® Scientific Ltd., a global leader in non-invasive breath analysis devices

Keensight Capital acquires majority stake in Bedfont® Scientific Ltd., a global leader in non-invasive breath analysis devices

Bedfont® to showcase the innovative Smokerlyzer® and NObreath® respiratory devices at ERS 2025

Bedfont® to showcase the innovative Smokerlyzer® and NObreath® respiratory devices at ERS 2025

OMED Health launches new gastrointestinal treatments and services through personalized Health Plans

OMED Health launches new gastrointestinal treatments and services through personalized Health Plans

Bedfont® Scientific Limited expands Middle East reach with Kuwaiti distributor

Bedfont® Scientific Limited expands Middle East reach with Kuwaiti distributor

Bedfont® Scientific Limited joins IFE Group to support young people’s mental health

Bedfont® Scientific Limited joins IFE Group to support young people’s mental health

World Wellbeing Week: Bedfont® Scientific Limited highlights ongoing investment in employee wellbeing

World Wellbeing Week: Bedfont® Scientific Limited highlights ongoing investment in employee wellbeing

Bedfont® Scientific Limited kicks-off in charity football match supporting local food education charity, Communigrow

Bedfont® Scientific Limited kicks-off in charity football match supporting local food education charity, Communigrow

Bedfont® Scientific Limited announces strategic partnership for the piCO™ Smokerlyzer® carbon monoxide (CO) device

Bedfont® Scientific Limited announces strategic partnership for the piCO™ Smokerlyzer® carbon monoxide (CO) device

WayBetter’s QuitBet app wins digital health award at Society of Behavioral Medicine conference

WayBetter’s QuitBet app wins digital health award at Society of Behavioral Medicine conference

Bedfont® Scientific Limited sponsors annual Bluebell Walk to raise vital funds for Heart of Kent Hospice

Bedfont® Scientific Limited sponsors annual Bluebell Walk to raise vital funds for Heart of Kent Hospice

New data highlights urgent need for better asthma care – How FeNO testing can help reduce hospitalizations

New data highlights urgent need for better asthma care – How FeNO testing can help reduce hospitalizations

Bedfont® Scientific Limited ranks 28th in MegaGrowth 50 awards 2025

Bedfont® Scientific Limited ranks 28th in MegaGrowth 50 awards 2025

SEHTA Healthcare Business Awards recognizes Bedfont® Scientific Limited for innovation

SEHTA Healthcare Business Awards recognizes Bedfont® Scientific Limited for innovation

Bedfont® Scientific Limited Concludes the Shaun in the Heart of Kent Trail by Presenting a CELLER8® Device to a Successful Participant

Bedfont® Scientific Limited Concludes the Shaun in the Heart of Kent Trail by Presenting a CELLER8® Device to a Successful Participant

Bedfont® Scientific Limited Secures a Double Win at the Kent Business Awards

Bedfont® Scientific Limited Secures a Double Win at the Kent Business Awards

Bedfont® Scientific Limited Brings Cutting-Edge Respiratory and Gastrointestinal Diagnostic Solutions to Saudi Arabia with New Registration

Bedfont® Scientific Limited Brings Cutting-Edge Respiratory and Gastrointestinal Diagnostic Solutions to Saudi Arabia with New Registration

Empowering Asthma Care: Bedfont® Scientific Limited Provides Vital Support for FeNO Testing in Response to Updated NICE Asthma Guidelines

Empowering Asthma Care: Bedfont® Scientific Limited Provides Vital Support for FeNO Testing in Response to Updated NICE Asthma Guidelines

Bedfont® Scientific Limited Host an Insightful Panel Discussion in Recognition of Stoptober

Bedfont® Scientific Limited Host an Insightful Panel Discussion in Recognition of Stoptober

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.